U.S. Supreme Court Won’t Review Nondismissal Of Union’s Avandia RICO Case

(June 6, 2016, 12:23 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on June 6 denied a motion by GlaxoSmithKline LLC (GSK) to review a trial court’s refusal to dismiss a Racketeer Influenced and Corrupt Organizations Act case brought by third-party payers involving the drug manufacturer’s marketing of the diabetes drug Avandia (GlaxoSmithKline LLC v. Allied Services Division Welfare Fund, et al., No. 15-1078, U.S. Sup.).

Allied Services Division Welfare Fund, the United Food and Commercial Workers Local 1776 and Participating Employers Health and Welfare Fund and the United Benefit Fund...
To view the full article, register now.